Comment on “Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review”

الملخص EN

We read with interest the article entitled “Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systemic Review,” which brings forward evidence that serum and faecal biomarkers do not possess adequate operational characteristics to make them stand-alone treatment targets in inflammatory bowel disease (IBD) but should be considered as important adjunctive measures to clinical, endoscopic, and radiographic assessment [1].